Drug class
Antitussives (Opioid Antitussives and DM)
The phrase "Antitussives (Opioid Antitussives and DM)" represents a combined functional category rather than a single standardized pharmacological class, grouping centrally acting opioid suppressants—principally codeine and hydrocodone—with dextromethorphan (DM), a synthetic morphinan derivative. Read more about Antitussives (Opioid Antitussives and DM)
1,151 drugs in this class 155 manufacturers
Drugs in Antitussives (Opioid Antitussives and DM)
MUCUS RLF COLD-FLU-SORE THROAT (phenylephrine HCl/dextromethorphan HBr/acetaminophen/guaifen)
MUCUS RLF COLD-FLU-SORE THROAT (phenylephrine HCl/dextromethorphan HBr/acetaminophen/guaifen)
DAYTIME-COLD NIGHTTIME-CLD-FLU (diphenhydramine/phenylephrin/dextromethorph/acetaminophen/GG)
DAY-NITE SEVERE COLD-FLU (doxylamine/phenylephrine/dextromethorphan/acetaminophen/GG)
TUSSIN NIGHTTIME COUGH DM (dextromethorphan HBr/doxylamine succinate)
VANATAB DM (guaifenesin/dextromethorphan HBr/phenylephrine)
TUSSIN DM (guaifenesin/dextromethorphan HBr)
HYDROCODONE-HOMATROPINE MBR (hydrocodone bitartrate/homatropine methylbromide)
The phrase "Antitussives (Opioid Antitussives and DM)" represents a combined functional category rather than a single standardized pharmacological class, grouping centrally acting opioid suppressants—principally codeine and hydrocodone—with dextromethorphan (DM), a synthetic morphinan derivative.
These agents act primarily within the central nervous system to elevate the cough reflex threshold in the brainstem, with opioids stimulating central mu-opioid receptors and dextromethorphan exerting non-opioid antitussive effects largely via sigma-1 receptor agonism and NMDA receptor antagonism.
Clinically, medications in this grouping are indicated for the short-term, symptomatic suppression of nonproductive cough associated with acute upper respiratory tract infections, allergies, and bronchitis.
-
fda.gov
The phrase "Antitussives (Opioid Antitussives and DM)" represents a combined functional category rather than a single standardized pharmacological class, grouping centrally acting opioid suppressants—principally codeine and hydrocodone—with dextromethorphan (DM), a synthetic morphinan derivative These agents act primarily within the central nervous system to elevate the cough reflex threshold in the brainstem, with opioids stimulating central mu-opioid receptors and dextromethorphan exerting non...
-
fda.gov
The phrase "Antitussives (Opioid Antitussives and DM)" represents a combined functional category rather than a single standardized pharmacological class, grouping centrally acting opioid suppressants—principally codeine and hydrocodone—with dextromethorphan (DM), a synthetic morphinan derivative
-
drugbank.com
The phrase "Antitussives (Opioid Antitussives and DM)" represents a combined functional category rather than a single standardized pharmacological class, grouping centrally acting opioid suppressants—principally codeine and hydrocodone—with dextromethorphan (DM), a synthetic morphinan derivative These agents act primarily within the central nervous system to elevate the cough reflex threshold in the brainstem, with opioids stimulating central mu-opioid receptors and dextromethorphan exerting non...
-
nih.gov
These agents act primarily within the central nervous system to elevate the cough reflex threshold in the brainstem, with opioids stimulating central mu-opioid receptors and dextromethorphan exerting non-opioid antitussive effects largely via sigma-1 receptor agonism and NMDA receptor antagonism
-
nih.gov
Clinically, medications in this grouping are indicated for the short-term, symptomatic suppression of nonproductive cough associated with acute upper respiratory tract infections, allergies, and bronchitis
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.